---
title: 'Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights
  from the 7<sup>th</sup> immunorad conference'
date: '2024-12-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39696783/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241219170844&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Over the last decade, the annual Immunorad Conference, held under the
  joint auspicies of Gustave Roussy (Villejuif, France) and the Weill Cornell Medical
  College (New-York, USA) has aimed at exploring the latest advancements in the fields
  of tumor immunology and radiotherapy-immunotherapy combinations for the treatment
  of cancer. Gathering medical oncologists, radiation oncologists, physicians and
  researchers with esteemed expertise in these fields, the Immunorad Conference bridges
  the ...
disable_comments: true
---
Over the last decade, the annual Immunorad Conference, held under the joint auspicies of Gustave Roussy (Villejuif, France) and the Weill Cornell Medical College (New-York, USA) has aimed at exploring the latest advancements in the fields of tumor immunology and radiotherapy-immunotherapy combinations for the treatment of cancer. Gathering medical oncologists, radiation oncologists, physicians and researchers with esteemed expertise in these fields, the Immunorad Conference bridges the ...